Terms: = Liver cancer AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4 AND Prognosis
11 results:
1. SNHG15 promotes gallbladder cancer progression by enhancing the autophagy of tumor cell under nutrition stress.
Min H; Yang L; Xu X; Geng Y; Liu F; Liu Y
Cell Cycle; 2023 Oct; 22(19):2130-2141. PubMed ID: 37937948
[TBL] [Abstract] [Full Text] [Related]
2. Integrated Analysis Highlights the Immunosuppressive Role of TREM2
Zhou L; Wang M; Guo H; Hou J; Zhang Y; Li M; Wu X; Chen X; Wang L
Front Immunol; 2022; 13():848367. PubMed ID: 35359989
[TBL] [Abstract] [Full Text] [Related]
3. Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.
Wang X; Xing Z; Xu H; Yang H; Xing T
Aging (Albany NY); 2021 Apr; 13(10):13822-13845. PubMed ID: 33929972
[TBL] [Abstract] [Full Text] [Related]
4. Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria.
Ye Q; Ling S; Jiang G; Shan Q; Xu S; Zhan Q; Wu Y; Liu Y; Zheng S; Xu X
Eur J Surg Oncol; 2021 Oct; 47(10):2533-2542. PubMed ID: 33902956
[TBL] [Abstract] [Full Text] [Related]
5. Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/tsc2 association in hepatocellular carcinoma.
Dong P; Wang X; Liu L; Tang W; Ma L; Zeng W; Sun S; Zhang L; Zhang N; Shen X; Janssen HLA; Dong L; Zhang S; Chen S
J Hepatol; 2020 Dec; 73(6):1446-1459. PubMed ID: 32610114
[TBL] [Abstract] [Full Text] [Related]
6. Expression of La Ribonucleoprotein Domain Family Member 4B (LARP4B) in liver cancer and Their Clinical and Prognostic Significance.
Li Y; Jiao Y; Li Y; Liu Y
Dis Markers; 2019; 2019():1569049. PubMed ID: 31772683
[TBL] [Abstract] [Full Text] [Related]
7. Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor.
Williamson LM; Steel M; Grewal JK; Thibodeau ML; Zhao EY; Loree JM; Yang KC; Gorski SM; Mungall AJ; Mungall KL; Moore RA; Marra MA; Laskin J; Renouf DJ; Schaeffer DF; Jones SJM
Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160355
[TBL] [Abstract] [Full Text] [Related]
8. Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma.
Zhu AX; Chen D; He W; Kanai M; Voi M; Chen LT; Daniele B; Furuse J; Kang YK; Poon RT; Vogel A; Chiang DY
J Hepatol; 2016 Aug; 65(2):296-304. PubMed ID: 27130844
[TBL] [Abstract] [Full Text] [Related]
9. Clinically advanced and metastatic pure mucinous carcinoma of the breast: a comprehensive genomic profiling study.
Ross JS; Gay LM; Nozad S; Wang K; Ali SM; Boguniewicz A; Khaira D; Johnson A; Elvin JA; Vergilio JA; Suh J; Miller VA; Stephens PJ
Breast Cancer Res Treat; 2016 Jan; 155(2):405-13. PubMed ID: 26762307
[TBL] [Abstract] [Full Text] [Related]
10. Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through tsc2-AKT cascade.
Guan DX; Shi J; Zhang Y; Zhao JS; Long LY; Chen TW; Zhang EB; Feng YY; Bao WD; Deng YZ; Qiu L; Zhang XL; Koeffler HP; Cheng SQ; Li JJ; Xie D
Hepatology; 2015 Dec; 62(6):1791-803. PubMed ID: 26257239
[TBL] [Abstract] [Full Text] [Related]
11. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract] [Full Text] [Related]
